172 related articles for article (PubMed ID: 32157993)
1. Biologics in Leprosy: A Systematic Review and Case Report.
Cogen AL; Lebas E; De Barros B; Harnisch JP; Faber WR; Lockwood DN; Walker SL
Am J Trop Med Hyg; 2020 May; 102(5):1131-1136. PubMed ID: 32157993
[TBL] [Abstract][Full Text] [Related]
2. Treatment of severe refractory erythema nodosum leprosum with tumor necrosis factor inhibitor Etanercept.
Chowdhry S; Shukla A; D'souza P; Dhali T; Jaiswal P
Int J Mycobacteriol; 2016 Jun; 5(2):223-5. PubMed ID: 27242236
[TBL] [Abstract][Full Text] [Related]
3. Thalidomide in the treatment of leprosy.
Teo S; Resztak KE; Scheffler MA; Kook KA; Zeldis JB; Stirling DI; Thomas SD
Microbes Infect; 2002 Sep; 4(11):1193-202. PubMed ID: 12361920
[TBL] [Abstract][Full Text] [Related]
4. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
de Carsalade GY; Achirafi A; Flageul B
Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD64 on Circulating Neutrophils Favoring Systemic Inflammatory Status in Erythema Nodosum Leprosum.
Schmitz V; Prata RB; Barbosa MG; Mendes MA; Brandão SS; Amadeu TP; Rodrigues LS; Ferreira H; Costa Fda M; Dos Santos JB; Pacheco Fdos S; Machado Ade M; Nery JA; Hacker Mde A; Sales AM; Pinheiro RO; Sarno EN
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004955. PubMed ID: 27556927
[TBL] [Abstract][Full Text] [Related]
6. [Some case reports which suggest correlation between biologics and leprosy, Mini-symposium on problems on leprosy].
Ishida Y
Nihon Hansenbyo Gakkai Zasshi; 2016 Jan; 84(3):133-7. PubMed ID: 27008827
[TBL] [Abstract][Full Text] [Related]
7. Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL).
Sampaio EP; Moraes MO; Nery JA; Santos AR; Matos HC; Sarno EN
Clin Exp Immunol; 1998 Feb; 111(2):300-8. PubMed ID: 9486396
[TBL] [Abstract][Full Text] [Related]
8. Real-world Effectiveness of Biologic Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis After Etanercept Discontinuation in the United Kingdom, France, and Germany.
Li N; Betts KA; Messali AJ; Skup M; Garg V
Clin Ther; 2017 Aug; 39(8):1618-1627. PubMed ID: 28729087
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India.
Upputuri B; Pallapati MS; Tarwater P; Srikantam A
PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008678. PubMed ID: 33035210
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate and prednisolone study in erythema nodosum leprosum (MaPs in ENL) protocol: a double-blind randomised clinical trial.
de Barros B; Lambert SM; Shah M; Pai VV; Darlong J; Rozario BJ; Alinda MD; Sales AM; Doni S; Hagge DA; Shrestha D; Listiawan MY; Yitaye AM; Nery JAC; Neupane KD; Dias VLA; Butlin CR; Nicholls PG; Lockwood D; Walker SL
BMJ Open; 2020 Nov; 10(11):e037700. PubMed ID: 33203627
[TBL] [Abstract][Full Text] [Related]
11. Leprosy reactions in postelimination stage: the Bangladesh experience.
Mowla MR; Ara S; Mizanur Rahman AFM; Tripura SP; Paul S
J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):705-711. PubMed ID: 27859670
[TBL] [Abstract][Full Text] [Related]
12. Reactional states in multibacillary Hansen disease patients during multidrug therapy.
Nery JA; Vieira LM; de Matos HJ; Gallo ME; Sarno EN
Rev Inst Med Trop Sao Paulo; 1998; 40(6):363-70. PubMed ID: 10436656
[TBL] [Abstract][Full Text] [Related]
13. A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum.
Polycarpou A; Walker SL; Lockwood DN
Front Immunol; 2017; 8():233. PubMed ID: 28348555
[TBL] [Abstract][Full Text] [Related]
14. Role of azathioprine in preventing recurrences in a patient of recurrent erythema nodosum leprosum.
Verma KK; Srivastava P; Minz A; Verma K
Lepr Rev; 2006 Sep; 77(3):225-9. PubMed ID: 17172003
[TBL] [Abstract][Full Text] [Related]
15. Use of anti-tumor necrosis factor biologics in the treatment of rheumatoid arthritis does not change human T-lymphotropic virus type 1 markers: a case series.
Umekita K; Umeki K; Miyauchi S; Ueno S; Kubo K; Kusumoto N; Takajo I; Nagatomo Y; Okayama A
Mod Rheumatol; 2015 Sep; 25(5):794-7. PubMed ID: 24252020
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor: status in reactions in leprosy before and after treatment.
Bhattacharya SN; Chattopadhaya D; Saha K
Int J Dermatol; 1993 Jun; 32(6):436-9. PubMed ID: 8320025
[TBL] [Abstract][Full Text] [Related]
17. ENLIST 1: An International Multi-centre Cross-sectional Study of the Clinical Features of Erythema Nodosum Leprosum.
Walker SL; Balagon M; Darlong J; Doni SN; Hagge DA; Halwai V; John A; Lambert SM; Maghanoy A; Nery JA; Neupane KD; Nicholls PG; Pai VV; Parajuli P; Sales AM; Sarno E; Shah M; Tsegaye D; Lockwood DN;
PLoS Negl Trop Dis; 2015; 9(9):e0004065. PubMed ID: 26351858
[TBL] [Abstract][Full Text] [Related]
18. Development of leprosy and type 1 leprosy reactions after treatment with infliximab: a report of 2 cases.
Scollard DM; Joyce MP; Gillis TP
Clin Infect Dis; 2006 Jul; 43(2):e19-22. PubMed ID: 16779736
[TBL] [Abstract][Full Text] [Related]
19. The role of thalidomide in the management of erythema nodosum leprosum.
Walker SL; Waters MF; Lockwood DN
Lepr Rev; 2007 Sep; 78(3):197-215. PubMed ID: 18035771
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
Becx-Bleumink M; Berhe D
Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
